Annunziata G, Verde L, Tarsitano MG, Stallone T, Grillo ARA, Santaniello MG, et al
Your prescribing physician can evaluate your symptoms and determine if an adjustment to your dosage is needed
Work with your healthcare provider to determine your optimal dose
Furthermore, in signaling studies that used cell lines with recombinantly expressed human GIPR or GLP-1R, tirzepatide stimulated cyclic adenosine monophosphate (cAMP) accumulation by either receptor with potency similar to that of native GIP and approximately 13-fold weaker than that of native GLP-1 [1]
Semaglutide trials reported 24-29% constipation rates while tirzepatide trials showed 12-27%
Because its riding that anti-pharma wave, it doesnt surprise me that berberine has taken off, says Derek Beres, a writer and podcaster who covers the intersection of wellness culture and conspiratorial thinking